10 July 2019

Milan Life Sciences Forum

10 July 2019 – The Milan Life Sciences Forum brings together the main players of the life sciences ecosystem at regional, national and international level, by creating a dialogue between businesses and institutions. The Forum aims to encourage the development of policies that favour the growth of the sector and cooperation between public and private sector, which is key for preserving and increasing the excellence and competitiveness of the life science sector in Italy and abroad. 

Marco Simoni, President of Human Technopole, took part in this year's edition by speaking on the panel dedicated to "Strategies for innovation, sustainability of national health system and competitiveness of life sciences at international level", alongside  Daniela Delledonne (Vice President, Confindustria Dispositivi Medici), Hubert de Ruty (Member, Farmindustria), Gabriele Pelissero (President, Lombardy Life Science Cluster) and Giuseppe Recchia (Vice President, Fondazione Smith Kline). 

The complete program for the Forum is available on Assolombarda's website. 

Share:

  • Facebook
  • Twitter
  • LinkedIn
  • Email

You could also like:

  • Colorectal Cancer: ML Enhances Cetuximab Response Predictions

    An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.

  • Human Technopole Foundation’s Supplier List online

    The Human Technopole Foundation’s Supplier Register is now online.

  • HT Director Zerial Awarded Mercurio Prize for Excellence in Research

    The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.

  • A polarized cortical assembly showing a spatial gradient of expression along its longitudinal axis (from left to right, colors from blue to yellow-red). @Camilla Bosone (IMBA)

    A new model system for cortical development in vitro

    Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.

  • The National Facility for Genomics with Clelia Peano

    Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.